Breast Cancer: New Diagnostic and Therapeutic Approaches
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 21
Special Issue Editors
Interests: ncRNAs; microRNAs; breast cancer; extracellular vesicles; tumor microenvironment; liquid biopsy
Interests: molecular characterization; circulating tumor cells; new methods development
Special Issue Information
Dear Colleagues,
As the most diagnosed form of cancer worldwide, breast cancer (BC) represents a major health issue. Despite the advances in breast oncology research, BC remains a highly lethal disease and ranks as the fifth cause of cancer-related deaths. In recent decades, researchers have intensively exploited next-generation sequencing (NGS) approaches to discover new actionable targets of breast tumor specimens, leading to the development of new therapy regimens (i.e., CDK4/6 inhibitors, PIK3CA inhibitors, etc.). More recently, novel approaches have been developed to improve cancer molecular characterization at epigenetic, transcriptomic, genetic and genomic levels. Moreover, the investigation of analytes retrievable in the peripheral blood (i.e., circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), extracellular vesicles (EVs), etc.) has demonstrated an unprecedented potential to obtain further information concerning the core tumor, and monitor treatment response and minimal residual disease. The topics of interest for this Special Issue can include, but are not limited to, the following:
- Prognostic and predictive biomarkers of breast cancer;
- Novel approaches to improve breast cancer characterization;
- Liquid biopsy in breast cancer;
- Genetic alterations in breast cancer
Dr. Erika Bandini
Dr. Tania Rossi
Dr. Sara Bravaccini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- breast oncology
- circulating tumor cells
